ABSTRACT
Kinematic models of contagion-based viral transmission describe patterns of events over time (e.g., new infections), relying typically on systems of differential equations to reproduce those patterns. By contrast, agent-based models of viral transmission seek to relate those events or patterns of events to causes, expressed in terms of factors (parameters) that determine the dynamics that give rise to those events.
This paper is concerned with the dynamics of contagion-based spread of infection. Dynamics that reflect time homogeneous vs inhomogeneous transmission rates are generated via an agent-based infectious disease modeling tool (CovidSIMVL - github.com/ecsendmail/MultiverseContagion). These different dynamics are treated as causal factors and are related to differences in vaccine efficacy in an array of simulated vaccination trials. Visualizations of simulated trials and associated metrics illustrate graphically some cogent reasons for not effectively hard-coding assumptions of dynamic temporal homogeneity, which come ‘pre-packaged’ with the mass action incidence assumption that underpins typical equation-based models of infection spread.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
N/A
Clinical Protocols
https://github.com/ecsendmail/MultiverseContagion
Funding Statement
The work is funded by the Michael Smith Foundation and the Victoria Hospitals Foundation. Dr. Moselle's time is covered by Island Health (Vancouver Island Health Authority) as the products are generated as a part of his organizationally mandated job responsibilities.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Work is funded by Michael Smith Foundation and Victoria Hospitals foundation in BC and has ethics approval from harmonized ethics review in BC (RISe)which is hosted by University of British Columbia. The work also has REB ethics approval and operational approval from Island Health (Vancouver Island Health Authority). The RISe ID is H20-02451
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The study presents results from an agent-based simulation modeling tool. Aggregated data re Distribution of SARS-CoV-2 Cased in British Columbia by Age are publicly available from the BC Centre for Disease Control (http://covid-19.bccdc.ca/)
